Mechanism of action
The mechanism by which DIACOMIT exerts its anticonvulsant effect in humans is unknown.
General use cases
- Seizures
- seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more
- seizures associated with Dravet syndrome in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
